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Summary To study whether colony growth in vitro reflects the prognosis of breast cancer patients, specimens
from a total number of 138 patients with primary breast carcinomas were cultivated in the Courtenay-Mills
soft agar method. The plating efficiency (PE) values were related to various clinical and histopathological
parameters. No significant correlation was found between colony forming ability and menopausal status,
histopathology, TNM-status or steroid hormone receptor status. The crude survival of the patients was not
significantly correlated to the in vitro growth of the tumours; neither was there any difference in relapse-free
survival between patients whose tumours failed to grow in vitro and those having growing tumours (PE>0).
A multivariate survival analysis of 115 patients with primary tumours without distant metastases revealed that
the PE was not a significant independent prognostic indicator, as it gave no additional prognostic information
above that of node and ER status. It is concluded that routine measurement of colony formation in vitro is
not warranted in the management of breast cancer.
In spite of intense efforts limited progress has been made in
recent years in the treatment of patients with breast
carcinoma and in most cases the long-term prognosis is still
poor.
In efforts to improve therapy it is important to identify
prognostic factors defining subgroups of patients that might
benefit from special treatment schedules. It is well
established that the prognosis of breast cancer is clearly
related to the number of affected lymph nodes (Nemoto et
al., 1980), the tumour size (Fisher et al., 1969) and the
oestrogen receptor level in the tumour (Hahnel et al., 1979).
Recently a number of papers have appeared on the
prognostic significance of cell kinetic parameters. The
proliferative activity of tumour cells measured by thymidine
labelling index (TLI) has been reported to have prognostic
value in breast carcinomas (Meyer et al., 1984; Tubiana et
al., 1984; Silvestrini et al., 1985), and DNA ploidy and
proliferative capacity (S-phase fraction) determined by flow
cytometry have been found to be predictive of relapse-free
and overall survival (Dressler et al., 1988; Kallioniemi et al.,
1988).
An important question is whether the aggressiveness of a
cancer and the clinical course of the disease can be judged
from the growth capacity of the cancer cells in vitro. Several
earlier investigators have examined the relationship between
colony forming ability of breast cancer cells in vitro and the
survival of the patients (Sutherland et al., 1983; Hug et al.,
1985; Dittrich et al., 1985; Aapro et al., 1987). However, the
results have been inconsistent and no clear conclusion has
emerged. Since the previous studies often failed to address a
clearly defined population and often involved a relatively
small number of patients and short observation times, we
have re-examined the issue on a substantially larger number
of patients.
Materials and methods
Patients
Primary tumour specimens from a total number of 138
patients hospitalised in the Norwegian Radium Hospital
during the years 1981-1986 were evaluated for colony
formation. All patients were females, with a mean age of 60
(30-87). Forty patients were premenopausal and 98 were
post-menopausal (women with more than 5 years of
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amenorrhoea). The disease was staged according to the
UICC classification. None of the patients had received any
treatment prior to the surgical intervention. Adjuvant post-
operative treatment (chemotherapy or tamoxifen) was given
according to clinical protocols.
Tumour material
The specimens were immediately put in ice-cold RPMI
medium supplemented with 100i.u.ml-1 penicillin and
100pgml-1 streptomycin. Within 20min, fat and necrotic
tissue, as well as normal breast tissue, were removed and
disaggregation was started.
Histology and cytology
All tumours were examined histologically by light
microscopy of Haematoxylin and Eosin stained sections
from formalin-fixed paraffin embedded material. In most
cases single cell suspensions were also examined under the
microscope after Papanicolaou staining of fixed cytospin
preparations.
Disaggregation and cultivation procedure
Disaggregation was performed enzymatically by a mixture of
collagenase, DNase and hyaluronidase, as described by
Ottestad et al. (1988). The disaggregated, filtered (by use of
a 45pm nylon mesh) and resuspended tumour cells were
cultivated in soft agar, essentially according to the method of
Courtenay & Mills (1978), as previously described (Tveit et
al., 1980, 1984). A total of 5 x 104 viable cells were plated
per tube. The experiments were set up in triplicate. Colonies
>60gm in diameter were scored. Usually, the number of
colonies per replicate tube were within +20% of the mean.
The plating efficiency (PE) was calculated as the number of
colonies in percentage of the number of viable cells plated.
To rule out the possibility of pre-existing cell clumps two
types of controls were used. In 62 of the tumours 10 pgml-'
of the toxin abrin was included, while in another 31 cases, a
day 1 count of cultures without erythrocytes was performed.
In none of these 93 cases were preculture clumps found that
could be misinterpreted as colonies. Moreover, the colony
formation was found to be closely similar in the two groups
where controls were used, and in the 45 cases where controls
were not included due to scarcity of cells.
Statistics
The difference in PEs between two groups was tested by
Wilcoxon's rank sum test. Two-way frequency tables were
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Table I Colony formation of primary breast carcinomas in relation to clinico-pathological parameters
Parameter
Menopausal status
Pre-menopausal
Post-menopausal
Histopathological type
Ductal
Non-ductal
Histopathological grade of ductal carcinomas
1
2
3
T-status
T1
T2
T3
T4
N-status
NO
N1
N2
N3
M-status
M0
M1
ER-status
< 10fmolmg-
>l10fmolmg-
PgR-status
<10 fmol mg-
> 10fmolmg- 1
a> 10 colonies formed.
Fraction of tumours
with colony forming
abilitya (%)
30/40 (75.0)
70/98 (71.4)
78/109 (71.6)
20/27 (74.1)
10/14 (71.4)
44/63 (69.8)
23/31 (74.2)
14/19
45/63
12/15
29/41
(73.7)
(71.4)
(80)
(70.7)
37/52 (71.2)
38/55 (69.1)
19/24 (79.2)
6/7 (85.7)
83/116 (71.6)
17/22 (77.3)
62/81 (76.5)
38/56 (76.9)
42/58 (72.4)
55/73 (75.3)
P value PE median (%)
0.055 ~0.67 0.038
0.79
0.67
0.87
0.79
0.58
0.26
0.70
0.050
0.020
0.040
0.05
0.040
0.038
0.044
0.040
0.040
0.033
0.059
0.034
0.021
0.050
tested by the X2 method. Survival was calculated by the life
table method of Cuthler & Ederer (1958), and differences
between survival curves were tested by the log rank test
(Peto et al., 1977). In patients who probably died of other
diseases, the time of death was treated as censored
observation in the survival analysis. The Cox proportional
hazards model (Cox, 1972; Elashoff, 1983) was used to
analyse the relative importance of several prognostic factors.
Stepwise analyses were performed and P values were
estimated with the likelihood ratio test. The assumption of
proportionality in the Cox model was tested with plot
(Dixon, 1985). All analyses were performed with the
BMDPC computer programs (Dixon, 1985).
Results
The relationship of the PEs of the primary tumours to
various clinical and histopathological parameters are given in
Table I.
Clinical and histopathological parameters
Of the 138 primary tumours, 40 were from premenopausal
and 98 from post-menopausal patients. The fraction of
Table II Multivariate survival analysis (Cox model) of primary
breast carcinomas (n= 137)
Possible prognostic factors P values
Metastatic disease no vs yesa <0.001
Nodal status no vs N1-3a <0.001
ER status >10 vs <10a <0.001
Tumour size T1-3 vs T4 0.17
Plating efficiency <0.1 vs >0.1 0.27
Age <50 vs >50 0.35
aGroup defined first had better survival.
tumours capable of forming colonies was not significantly
different in the two groups, and the median PEs were also
similar (Table I).
Similar fractions of colony-forming tumours were found in
ductal and non-ductal carcinomas (Table I), and the median
PEs did not differ significantly. With respect to the
differentiation stage of the ductal breast carcinomas, most
tumours were of WHO grade 2. No statistically significant
difference in the fraction of colony-forming tumours or in
the median PEs was found when the tumours of WHO
grades 1 and 2 combined were compared with grade 3
tumours (Table I).
The colony-forming ability, revealed as the fraction of
colony-forming tumours and the median PE, was unaffected
by T-status, N-status and M-status (Table I).
In the present study, the fraction of tumours capable of in
vitro growth was the same in the hormone receptor-positive
and the receptor-negative groups (Table I). The ER-negative
tumours had higher median PEs than ER-positive tumours,
while the opposite was found in the case of PgR. However,
the differences were not statistically significant.
Survival
The median follow-up period was 74 months. The difference
in crude survival between patients with tumours unable to
Table III Multivariate survival analysis (Cox model) of primary
breast carcinomas without distant metastases (n=115)
Possible prognostic factors P values
Nodal status NO vs N1-3' <0.001
ER status >10 vs <o10a <0.001
Age <50 vs >50 0.13
Tumour size T1-3 vs T4 0.17
Plating efficiency <0.1 vs >0.1 0.17
aGroup defined first had better survival.
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Figure 1 Crude survival for patients with primary breast
carcinomas according to colony-forming ability. O, PE=0%; 0,
PE >0%.
grow in vitro under our conditions (PE=0) and those with
tumours that did form colonies (PE>0) was not statistically
significant (Figure 1). Moreover, no difference in relapse-free
survival was observed. Also, when the patients were divided
into different quartiles with respect to PE, no statistically
significant difference was found between the different groups
for crude or relapse-free survival. If patients with metastases
and T4 tumours were excluded from the survival analyses, a
grouped PE did not separate the survival curves.
In a subgroup of 67 node-positive patients without distant
metastases, the 16 patients with primary tumours showing
good growth in vitro (PE>0.1) had a significantly worse
prognosis than patients with non-growing and poorly
growing tumours (PEB<0.1) (P=0.005) (Figure 2). The
number of involved nodes or the ER level did not differ
significantly in the PE<0.1 and PE>0.1 groups of node-
positive patients.
A multivariate survival analysis was carried out on the 137
patients as well as on the 115 patients with primary tumours
who had no distant metastases (67 node-positive and 48
node-negative). Plating efficiency competed with the known
prognostic factors nodal status and ER status, tumour size
and age. The best plot of the proportional hazards was
obtained with PE<0.1. However, this grouped PE was not a
significant prognostic factor in addition to nodal and ER
status (Tables II and III). The variables in the tables refer to
the order in which they were entered in the multivariate
analyses
Discussion
The main question raised here, whether the colony forming
ability of tumour cells in soft agar is correlated with the
prognosis of the patient, is of considerable general interest.
If the malignancy of a tumour could be predicted on the
basis of an in vitro assay of its growth potential, this could
have therapeutic implications.
Indications have previously been obtained by some
authors that in vitro growth may be related to in vivo
malignancy. Thus, Sutherland et al. (1983) found in a
survival analysis restricted to stage IV patients that
increasing colony count was associated with decreasing
survival, and later Aapro et al. (1987) found a trend towards
shorter time to relapse and death with increasing number of
colonies, but there was no statistically significant correlation
between colony forming ability and crude survival. In
contrast, the present results, in general agreement with the
findings of Dittrich et al. (1985), showed no statistically
significant difference between the survival of patients whose
tumours failed to grow in vitro and those with growing
tumours. Neither did we find any difference in relapse-free
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Figure 2 Crude survival for patients with primary breast
carcinomas with lymph node involvement according to colony
forming ability. O, PE<O; 0.1%, PE>0.1%.
survival between these groups. Altogether, our results on a
relatively large number of patients with adequate observation
time, together with those of Dittrich et al. (1985) provide
strong evidence that growth potential in vitro is not a reliable
indicator of malignancy in vivo.
The assumption that the growth of cancer cells in vitro
should reflect the biological aggressiveness of the tumour
cells and the clinical course of the disease appears reasonable
at first sight. There are, however, several reasons why this
may in fact not be so. The in vivo growth of cancer cells is
the result of an interplay between the malignant cells and a
variety of host factors, and the growth conditions in vivo are
entirely different from those in vitro. The growth of different
cancers in semi-solid medium expresses their capacity for
growth under the particular culture conditions used and does
not necessarily reflect the intrinsic growth potential of the
cells. Different cancers have different growth requirements,
and even closely related tumours may differ in this respect.
We have made considerable efforts to optimise the
conditions for growing breast cancer cells in vitro and have
found (Ottestad et al., 1988) that more breast carcinomas
will grow in soft agar and higher PEs are obtained with the
Courtenay-Mills assay than with the Hamburger-Salmon
assay (Hamburger & Salmon, 1977). However, the observed
PEs are still low; in most cases no more than 10 out of
10,000 cells plated gave rise to colonies. Possibly, other
culture conditions may select different cell populations, and
other relationships between colony formation and clinical and
histopathological parameters than found here might emerge.
However, the difference between our results and those of
Sutherland et al. (1983) and Aapro et al. (1987) can hardly
be accounted for by the fact that different colony forming
assays were used, since Dittrich et al. (1985), like Sutherland
et al. (1983), used the H-S assay.
The lack of significant correlation between colony
formation in vitro and the prognosis of the patients from
whom the cells were derived emphasises the limitations of in
vitro growth assays and the great importance of host factors
for the clinical course of the disease. The conclusion seems
inescapable that measurements of colony formation of breast
carcinoma cells in vitro do not provide significant additional
prognostic information and hence that routine measurements
of colony formation in vitro is not warranted in the
management of breast cancer. It seems likely that in other
cancer forms as well, colony formation in vitro may not
predict adequately the malignancy of the disease. Probably
other parameters measurable in vitro, such as the DNA
content of tumour cells, may prove to be more useful as
predictors of the clinical course of the disease.
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